PubRank

Mark D Eisner

Author PubWeight™ 128.99‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Lebrikizumab treatment in adults with asthma. N Engl J Med 2011 8.07
2 Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome. N Engl J Med 2002 6.17
3 Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med 2005 5.76
4 An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010 3.92
5 Recent trends in acute lung injury mortality: 1996-2005. Crit Care Med 2009 3.86
6 Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome. Crit Care Med 2007 3.31
7 Randomized clinical trial of activated protein C for the treatment of acute lung injury. Am J Respir Crit Care Med 2008 3.28
8 COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 2005 2.88
9 Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders. Crit Care Med 2007 2.79
10 Higher urine nitric oxide is associated with improved outcomes in patients with acute lung injury. Am J Respir Crit Care Med 2006 2.61
11 Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. Am J Respir Crit Care Med 2004 2.49
12 Active and passive cigarette smoking and acute lung injury after severe blunt trauma. Am J Respir Crit Care Med 2011 2.39
13 Subpicogram per milliliter determination of the tobacco-specific carcinogen metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine using liquid chromatography-tandem mass spectrometry. Anal Chem 2008 2.27
14 Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 2004 2.15
15 Racial and ethnic disparities in mortality from acute lung injury. Crit Care Med 2009 2.14
16 A comprehensive study of the direct and indirect costs of adult asthma. J Allergy Clin Immunol 2003 2.11
17 Are patients with asthma at increased risk of coronary heart disease? Int J Epidemiol 2004 1.97
18 Prognostic value of surfactant proteins A and D in patients with acute lung injury. Crit Care Med 2003 1.96
19 A simple clinical predictive index for objective estimates of mortality in acute lung injury. Crit Care Med 2009 1.91
20 Biomarkers increase detection of active smoking and secondhand smoke exposure in critically ill patients. Crit Care Med 2011 1.86
21 Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial. Ann Intern Med 2011 1.86
22 Before diagnostic testing for pulmonary embolism: estimating the prior probability of disease. Am J Med 2003 1.78
23 Predictive and pathogenetic value of plasma biomarkers for acute kidney injury in patients with acute lung injury. Crit Care Med 2007 1.73
24 Measuring disease-specific quality of life in obstructive airway disease: validation of a modified version of the airways questionnaire 20. Chest 2006 1.72
25 Acute effects of tidal volume strategy on hemodynamics, fluid balance, and sedation in acute lung injury. Crit Care Med 2005 1.70
26 Trends in the incidence of noncardiogenic acute respiratory failure: the role of race. Crit Care Med 2012 1.67
27 Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injury. Intensive Care Med 2008 1.61
28 Comparison of urine cotinine and the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and their ratio to discriminate active from passive smoking. Nicotine Tob Res 2011 1.50
29 Plasma granulocyte colony-stimulating factor levels correlate with clinical outcomes in patients with acute lung injury. Crit Care Med 2009 1.47
30 Depression and health-related quality of life in chronic obstructive pulmonary disease. Am J Med 2009 1.44
31 Obstructive lung disease among the urban homeless. Chest 2004 1.33
32 Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury. Crit Care Med 2011 1.31
33 Exposure to vapors, gas, dust, or fumes: assessment by a single survey item compared to a detailed exposure battery and a job exposure matrix. Am J Ind Med 2005 1.26
34 COPD and cognitive impairment: the role of hypoxemia and oxygen therapy. Int J Chron Obstruct Pulmon Dis 2010 1.23
35 Effect of race on asthma management and outcomes in a large, integrated managed care organization. Arch Intern Med 2007 1.22
36 Perceived neighborhood problems and quality of life, physical functioning, and depressive symptoms among adults with asthma. Am J Public Health 2006 1.19
37 Higher urine desmosine levels are associated with mortality in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 2006 1.18
38 Adult asthma and risk of coronary heart disease, cerebrovascular disease, and heart failure: a prospective study of 2 matched cohorts. Am J Epidemiol 2012 1.17
39 Impact of the home indoor environment on adult asthma and rhinitis. J Occup Environ Med 2005 1.11
40 BMI and health status among adults with asthma. Obesity (Silver Spring) 2008 1.10
41 The influence of perceived control of asthma on health outcomes. Chest 2006 1.08
42 The impact of allergy and pulmonary specialist care on emergency asthma utilization in a large managed care organization. Health Serv Res 2005 1.06
43 Performance of valued life activities reflected asthma-specific quality of life more than general physical function. J Clin Epidemiol 2004 1.02
44 Perceived control of asthma and quality of life among adults with asthma. Ann Allergy Asthma Immunol 2002 1.01
45 Asthma and the prospective risk of anaphylactic shock and other allergy diagnoses in a large integrated health care delivery system. Ann Allergy Asthma Immunol 2010 1.00
46 Obstructive sleep apnea: a risk factor for work disability. Sleep 2009 0.97
47 Health-related quality of life in adult rhinitis: the role of perceived control of disease. J Allergy Clin Immunol 2004 0.96
48 Aggressive management of lung donors classified as unacceptable: excellent recipient survival one year after transplantation. J Thorac Cardiovasc Surg 2002 0.96
49 Further exploration of the links between occupational exposure and chronic obstructive pulmonary disease. J Occup Environ Med 2009 0.95
50 Exposure to traffic: lung function and health status in adults with asthma. J Allergy Clin Immunol 2009 0.95
51 Risk factors for death in adults with severe asthma. Ann Allergy Asthma Immunol 2008 0.95
52 Impact of perceived neighborhood problems on change in asthma-related health outcomes between baseline and follow-up. Health Place 2007 0.93
53 The COPD severity score: a dynamic prediction tool for health-care utilization. COPD 2008 0.93
54 Matrix metalloproteinase-9 predicts pulmonary status declines in α1-antitrypsin deficiency. Respir Res 2011 0.92
55 Respiratory and skeletal muscle strength in chronic obstructive pulmonary disease: impact on exercise capacity and lower extremity function. J Cardiopulm Rehabil Prev 2011 0.91
56 Effects of physician-related factors on adult asthma care, health status, and quality of life. Am J Med 2003 0.91
57 Urine cotinine underestimates exposure to the tobacco-derived lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in passive compared with active smokers. Cancer Epidemiol Biomarkers Prev 2010 0.91
58 Impact of exogenous glucocorticoid use on salivary cortisol measurements among adults with asthma and rhinitis. Psychoneuroendocrinology 2005 0.90
59 Screening for depression in chronic obstructive pulmonary disease. COPD 2009 0.90
60 The COPD Helplessness Index: a new tool to measure factors affecting patient self-management. Chest 2009 0.89
61 Omalizumab and the risk of malignancy: results from a pooled analysis. J Allergy Clin Immunol 2012 0.89
62 Functioning and psychological status among individuals with COPD. Qual Life Res 2005 0.88
63 Banning smoking in public places: time to clear the air. JAMA 2006 0.88
64 Occupational exposures are associated with worse morbidity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2015 0.87
65 The impact of disability on depression among individuals with COPD. Chest 2009 0.86
66 Smoking and adult asthma: a healthy smoker effect? Am J Respir Crit Care Med 2002 0.84
67 Socioeconomic gradients in tiotropium use among adults with COPD. Int J Chron Obstruct Pulmon Dis 2008 0.82
68 Secondhand smoke and obstructive lung disease: a causal effect? Am J Respir Crit Care Med 2009 0.82
69 An integrated model of environmental factors in adult asthma lung function and disease severity: a cross-sectional study. Environ Health 2010 0.82
70 Onset of depressive symptoms among adults with asthma: results from a longitudinal observational cohort. Prim Care Respir J 2010 0.80
71 An official American Thoracic Society workshop report: tobacco control initiatives within the American Thoracic Society. Proc Am Thorac Soc 2010 0.80
72 Leukotriene modifier use and asthma severity: how is a new medication being used by adults with asthma? Arch Intern Med 2004 0.79
73 Risk adjustment for health care financing in chronic disease: what are we missing by failing to account for disease severity? Med Care 2013 0.79
74 Clinical year in review II: Sepsis, mechanical ventilation, occupational and environmental lung disease, and sleep. Proc Am Thorac Soc 2009 0.77
75 Concomitant asthma medications in moderate-to-severe allergic asthma treated with omalizumab. Respir Med 2012 0.77
76 Passive smoking, lung function, and public health. Am J Respir Crit Care Med 2006 0.77
77 Passive smoking and cognitive impairment. BMJ 2009 0.75
78 Endovascular vs. open repair of abdominal aortic aneurysms. N Engl J Med 2008 0.75
79 The challenge of subgroup analyses. N Engl J Med 2006 0.75
80 Asthma and influenza vaccination. Chest 2003 0.75
81 Population-based efficacy modeling of omalizumab in patients with severe allergic asthma inadequately controlled with standard therapy. AAPS J 2013 0.75
82 The impact of a "low-intensity" versus "high-intensity" medical intensive care unit on patient outcomes in critically ill veterans. J Intensive Care Med 2010 0.75
83 Indoor air, passive smoking, and COPD. Am J Respir Crit Care Med 2007 0.75
84 Smoke-free legislation and acute coronary syndrome. N Engl J Med 2008 0.75
85 Interferon gamma-1b for pulmonary fibrosis. N Engl J Med 2004 0.75
86 Environmental factors and asthma: what we learned from epidemiological studies. Preface. Immunol Allergy Clin North Am 2008 0.75
87 Environmental tobacco smoke exposure and adult asthma. Chest 2002 0.75